• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

GE gets go-ahead for NT workstations

Article

GE gets go-ahead for NT workstationsThe Integrated Imaging Solutions division of GE Medical Systems has received Food and Drug Administration 510(k) clearance for its Platinum line of Windows NT-based diagnostic and clinical review workstations

GE gets go-ahead for NT workstations

The Integrated Imaging Solutions division of GE Medical Systems has received Food and Drug Administration 510(k) clearance for its Platinum line of Windows NT-based diagnostic and clinical review workstations (

PNN

4/98). The news is an important milestone for GE as the vendor seeks dominance in a PACS market where NT-based solutions are increasingly in demand. Shipments are expected to begin in the fourth quarter of this year.

In other GE news, the Milwaukee-based company has received a $1.3 million contract from Precedent Health Center in Denver that covers equipment and service agreements and includes three high-resolution workstations for diagnostic reading. Four clinical review workstations will be placed in multiple departments. Ultrasound, CT, MRI, fluoroscopy, CR, and nuclear medicine will be hooked to the PACS, and two film digitizers will be installed.

Recent Videos
Computed Tomography Study Shows Emergence of Silicosis in Engineered Stone Countertop Workers
Can an Emerging AI Software for DBT Help Reduce Disparities in Breast Cancer Screening?
Skeletal Muscle Loss and Dementia: What Emerging MRI Research Reveals
Magnetoencephalopathy Study Suggests Link Between Concussions and Slower Aperiodic Activity in Adolescent Football Players
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Can 18F-Floutufolastat Bolster Detection of PCa Recurrence in Patients with Low PSA Levels After Radical Prostatectomy?
Related Content
© 2024 MJH Life Sciences

All rights reserved.